Michael Goodman. Show Affiliations »
Abstract
Mesh： See more » Angiogenesis Inhibitors/economicsAnti-Inflammatory Agents/economicsAntibodies, Monoclonal/economicsAntibodies, Monoclonal, HumanizedAntipsychotic Agents/economicsAripiprazoleBevacizumabCosts and Cost AnalysisDrug Industry/economicsDrug Industry/standardsDrug Industry/trendsDrug Therapy/economicsDrug and Narcotic Control/trendsHumansInfliximabMarketing of Health Services/economicsPiperazines/economicsQuinolones/economicsRewardUnited States
Substances： See more » Angiogenesis InhibitorsAnti-Inflammatory AgentsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntipsychotic AgentsPiperazinesQuinolonesBevacizumabAripiprazoleInfliximab
Year: 2008 PMID： 19043444 DOI： 10.1038/nrd2768
Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694